Report
Stamatios Draziotis CFA
EUR 300.00 For Business Accounts Only

OPAP | Heads up – Q2’23: healthy trends, cash returns continuing

Rating: Buy (top pick)
Target Price: EUR 18.00 from EUR 17.90

Rating: Buy (top pick)
Target Price: EUR 18.00 from EUR 17.90

Q2’23 on 4th Sep; 2-digit top line growth, +7% EBITDA, >€0.30 interim DPS – OPAP’s Q2 is likely to affirm that momentum remains healthy, with revenues up in the 2-digits yoy (EEe +10% at €488m) propelled by online growth and the retracement of retail to above pre-COVID levels. Although costs ought to dilute somewhat the top line growth (e.g. personnel and marketing), we still forecast EBITDA up +7% yoy at €179m, quite a respectable performance. Coupled with lower financing costs, this will lead to a >30% yoy increase in EPS (net profit €110m on our estimate). Given the substantial increase in profitability, we believe it is reasonable to expect an interim DPS higher than the one paid last year (€0.30), with our numbers penciling in €0.35 (and €1.55 in total for FY23). We also expect strong FCF generation (c€125m) partly absorbing the cash returns to shareholders (final DPS of 2022 and capital return) thus leading to a net debt position of €109m (from €77m net cash in Q1’23).

Housekeeping ahead of Q2; higher top line and costs, unchanged profit outlook – Ahead of Q2, we have recalibrated our model making trivial changes to our operating assumptions, factoring in better top line trends offset by higher costs. Overall, we end up with little-changed EBITDA, still landing at €770m, just a bit above guidance for 2023 (max €760m), while making minor net profit upgrades on account of lower financial expenses. We input 8%/5% growth in 2023-24e GGR based on 2-digit growth in online and 6%/3% growth in retail. This will filter through to 5%/3% growth in EBITDA over 2023-24e, which will support shareholder returns near €1.6/share during both years, namely quite a compelling c10-11% yield. We remind that returns will be further underpinned by potential earnouts related to the Betano stake sale (c€130m assumed in our numbers through to 2025e).

Unique business model – OPAP runs a franchise-based model, as a result of which it is an “asset-light” business with minimal capex needs (after licences have been secured), limited working capital risk and relatively immune from severe cost pressures. This is in stark contrast with other retail (e.g. Tabcorp) or online-skewed peers (e.g. Entain) with lower EBITDA margins (80% of EBITDA) supports an elevated EV/EBITDA multiple, in the high single-digits, especially as the bulk of FCF flows through to shareholders in the form of cash returns.

Valuation: renewal optionality, cash returns; top pick – Our PT is based on a SOTP of OPAP’s concessions at 7.6% WACC. We have lifted our PT slightly to €18.0 rolling forward our valuation to Aug’24. Our PT implies a 2023e EV/EBITDA of c8.8x, modest premium vs OPAP’s historic average but still discount vs best-in-class peers such as Flutter and Entain. Despite the 23% total return ytd, we still find the investment case compelling arguing that the stock resembles a high yield bond with investment-grade fundamentals offering coupon-like yield of >10% plus price appreciation potential from re-rating and crystallization of licence renewal optionality.
Underlying
Greek Organisation of Football Prognostics SA

OPAP is engaged in the operating and management of numerical lottery and sports betting games as well as lottery games. Co. holds concession to operate and manage new sports betting games in Greece as well as a right of first refusal to operate and manage any new lottery games permitted by the Hellenic Republic. Co. operates six numerical lottery games, including Joker, Lotto, Proto, Extra 5, Super 3, and Kino; and three sports betting games consisting of Stihima, Propo, and Propo-goal. Co. is also engaged in designing new lottery games, including Bingo and Super 4. Co. distributes its games through an extensive on-line network of agents.

Provider
Eurobank Equities
Eurobank Equities

Eurobank Equities is a Greek-based firm offering research, sales and trading services to institutional, corporate and private clients. The company is wholly owned by Eurobank, one of the 4 systemic banks in Greece.

Research is the backbone of Eurobank Equities' platform, with a team of 4 professionals committed to generating actionable investment ideas by providing timely research products. We are committed to offering value-added services to clients by filtering market noise and providing insights on the multiple sectors that we cover. Our universe includes 26 - large, medium and small cap - companies whose market capitalization amounts to 80-85% of the total market capitalization of the Athens Stock Exchange. Our research team also maintains the capacity to generate ad-hoc research for micro-cap listed companies.

Our team has consistently gained recognition among institutional investors for its quality research, having ranked No. 1 team in Greece at the Extel Surveys of 2013-2016 and 2018. We have also been named Leading Brokerage Firm in Greece over 2014-2016 and in 2018.

Analysts
Stamatios Draziotis CFA

Other Reports on these Companies
Other Reports from Eurobank Equities

ResearchPool Subscriptions

Get the most out of your insights

Get in touch